trending Market Intelligence /marketintelligence/en/news-insights/trending/p6DMBuBi7mXx9W8k9BCHOA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

US FDA clears Immunicum's application for renal cell cancer drug

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


US FDA clears Immunicum's application for renal cell cancer drug

Immunicum AB (publ) said the U.S. FDA cleared the company's investigational new drug application for INTUVAX for the treatment of metastatic renal cell cancer.

The clearance enables the company to expand its ongoing phase 2 study in the U.S.